PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance

U.S. Markets close in 3 hrs 3 mins

Pfizer Inc. (PFE)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
34.10-0.08 (-0.23%)
As of 12:57PM EDT. Market open.
People also watch
MRKJNJJPMGEINTC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close34.18
Open34.06
Bid0.00 x
Ask0.00 x
Day's Range33.97 - 34.24
52 Week Range29.41 - 37.39
Volume8,238,219
Avg. Volume25,216,455
Market Cap203.08B
Beta1.04
PE Ratio (TTM)29.07
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.76%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe
    Zacks1 hour ago

    Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe

    Pfizer, Inc.'s (PFE) rheumatoid arthritis (RA) drug, Xeljanz has received marketing approval in Europe.

  • Barrons.com1 hour ago

    [$$] Could Pfizer Make Cash Bid for Bristol-Myers?

    Credit Suisse One of the most common topics of discussion in our investor meetings remains the question around whether Pfizer or another biopharma company may be interested in acquiring Bristol-Myers Squibb in the next nine-12 months, given some of the challenges Bristol-Myers is facing and the activist involvement in the name. To supplement our previous work, our HOLT [proprietary Credit Suisse platform] colleagues have now taken a look at the possibility of Pfizer buying Bristol-Myers from a HOLT perspective and do see the deal as providing an opportunity for value-creation.

  • 3 Top Cancer Drug Stocks to Buy in 2017
    Motley Fool20 hours ago

    3 Top Cancer Drug Stocks to Buy in 2017

    These are the best oncology-focused stocks you can buy this year. Find out which is best suited to boost your portfolio's performance.